EVMN · Insider trading · 13F holders · Congress trades
Evommune, Inc. (EVMN)
Who is buying and selling EVMN: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 12
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $0
- Congress trades, 12 months
- 0
EVMN at a glance
- No open-market insider purchases or sales of EVMN were filed in the last 90 days.
- 12 13F filers hold EVMN among their 50 largest positions, worth $217.6M combined, including Peter Kolchinsky. The biggest bets by portfolio weight are Nan Fung Group Holdings Ltd (14.6%), Pivotal bioVenture Partners Investment Advisor LLC (8.3%) and Velan Capital Investment Management LP (3.7%). In their latest 13Fs, 1 manager opened a new position and 3 added to one.
- No member of Congress has disclosed a trade in EVMN.
EVMN insider trading
No open-market insider purchases or sales of EVMN were filed in the last 90 days.
Who owns EVMN? Hedge funds and superinvestors
12 13F filers hold EVMN among their 50 largest positions, worth $217.6M combined, including Peter Kolchinsky. The biggest bets by portfolio weight are Nan Fung Group Holdings Ltd (14.6%), Pivotal bioVenture Partners Investment Advisor LLC (8.3%) and Velan Capital Investment Management LP (3.7%). In their latest 13Fs, 1 manager opened a new position and 3 added to one.
Superinvestors holding EVMN: Peter Kolchinsky 0.4%
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| EQT Fund Management S.a r.l.Hedge fund | 8.1% | $70.3M | 5,288,313 | +7.3% shares | Q2 2026 |
| Peter KolchinskyHedge fund | 0.4% | $46.4M | 3,494,638 | +0.0% shares | Q2 2026 |
| SymBiosis Capital Partners, LLCHedge fund | 55.8% | $29.4M | 1,280,778 | +0.0% shares | Q1 2026 |
| Pivotal bioVenture Partners Investment Advisor LLCVenture capital | 8.3% | $25.6M | 1,926,943 | +0.0% shares | Q2 2026 |
| Nan Fung Group Holdings LtdInvestment manager | 14.6% | $19.2M | 1,441,032 | +0.0% shares | Q2 2026 |
| Defilade Capital Management, L.P.Hedge fund | 1.4% | $10.5M | 793,145 | +16.9% shares | Q2 2026 |
| Velan Capital Investment Management LPHedge fund | 3.7% | $6.0M | 451,255 | +1.1% shares | Q2 2026 |
| Great Point Partners LLCHedge fund | 1.0% | $4.3M | 325,000 | +0.0% shares | Q2 2026 |
| Blue Owl Capital Holdings LPHedge fund | 0.4% | $2.4M | 180,000 | +80.0% shares | Q2 2026 |
| NEXTBio Capital Management LPHedge fund | 0.7% | $1.6M | 119,063 | -35.3% shares | Q2 2026 |
| Avidity Partners Management LPHedge fund | 0.2% | $997K | 75,000 | New | Q2 2026 |
| Andera PartnersHedge fund | 0.5% | $804K | 97,362 | -93.0% shares | Q3 2026 |
Each manager counts with its latest 13F (Q3 2026: 1, Q2 2026: 10, Q1 2026: 1). Screen EVMN in the grand portfolio →
EVMN stock trades by members of Congress
No member of Congress has disclosed a trade in EVMN.
EVMN questions and answers
Are insiders buying EVMN stock?
No open-market insider purchases or sales of EVMN were filed in the last 90 days.
Which hedge funds own EVMN?
12 13F filers hold EVMN among their 50 largest positions, worth $217.6M combined, including Peter Kolchinsky. The biggest bets by portfolio weight are Nan Fung Group Holdings Ltd (14.6%), Pivotal bioVenture Partners Investment Advisor LLC (8.3%) and Velan Capital Investment Management LP (3.7%). In their latest 13Fs, 1 manager opened a new position and 3 added to one.
Has Congress traded EVMN?
No member of Congress has disclosed a trade in EVMN.
Who is the largest holder of EVMN?
Among 13F filers, EQT Fund Management S.a r.l. reports the largest EVMN position, $70.3M (5,288,313 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Nan Fung Group Holdings Ltd's: 14.6% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.